Validation study of the Korean version of the M. D. Anderson Symptom Inventory.
This study aimed to evaluate the Korean version of the M. D. Anderson Symptom Inventory (MDASI-K) as a tool for assessing multiple symptoms in Korean cancer patients. Participants (178 cancer patients and 178 age and sex-matched community-dwelling adults) completed the MDASI-K and the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30. The MDASI-K exhibited substantial reliability and validity. Cronbach alpha coefficients were 0.91 and 0.93 in the cancer patients, and 0.96 and 0.96 in the normal group for both symptom and interference, respectively. MDASI-K summary scores correlated significantly with those of the EORTC QLQ-C30. Discriminant validity of the MDASI-K was demonstrated by its ability to clearly distinguish significant differences within different Eastern Cooperative Oncology Group performance statuses and those between the patient and normal groups in the mean scores of both symptom and interference. The MDASI-K is a valid and reliable measure for assessing multiple symptoms in Korean cancer patients.
Yun
Young Ho
YH
Quality of Cancer Care Branch, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea. lawyun08@ncc.re.kr
Mendoza
Tito R
TR
Kang
Im Ok
IO
You
Chang Hoon
CH
Roh
Ju Won
JW
Lee
Chang Geol
CG
Lee
Won Sup
WS
Lee
Keun Seok
KS
Bang
Soo-Mee
SM
Park
Sang Min
SM
Cleeland
Charles S
CS
Wang
Xin Shelley
XS
D000328:Adult; D005260:Female; D006304:Health Status; D006306:Health Surveys; D006801:Humans; D007723:Korea; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000503:physiopathology / Q000523:psychology*; D011788:Quality of Life; D015203:Reproducibility of Results; D012959:Socioeconomic Factors